bpc-157 human clinical trials dose dosage BPC-157 Dosing (Common Protocols), ๐น Oral / Subcutaneous, โข 500 mcg daily, โข Duration: 6 weeks, ๐น Intramuscular / Peritendinous, โข 1 mg daily, โข Duration: 6 weeks, โ ๏ธ Note:, Not approved by FDA or How to Reconstitute BPC-157: Step-by-Step
Description
Caplan listens & investigates

This supplement is not intended to diagnose, treat, cure, or prevent any disease
Damage to the endplate disrupts the nutritional supply to the disc and alters the biomechanical environment, accelerating degenerative processes
When combining approaches, timing considerations apply
